BRIDGEBIO PHARMA INC.
26.73
08-November-24 14:28:51
15 minutes delayed
Stocks
+0.85
+3.28%
Today's range
25.57 - 26.93
ISIN
N/A
Source
NASDAQ
-
BridgeBio Pharma Announces Pricing of Public Offering of Common Stock
08 Mar 2023 06:00:01 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Announces Proposed Public Offering of Common Stock
06 Mar 2023 15:05:38 By Nasdaq GlobeNewswire
-
BridgeBio to Host Investor Call to Discuss Phase 2 Cohort 5 Data for Achondroplasia on March 6, 2023
03 Mar 2023 06:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Fourth Quarter and Full Year 2022 Financial Results and Business Update
23 Feb 2023 06:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
17 Feb 2023 06:30:00 By Nasdaq GlobeNewswire
-
13 Feb 2023 06:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma to Participate in February and March Investor Events
08 Feb 2023 06:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma to Present at the J.P. Morgan Healthcare Conference
04 Jan 2023 06:30:00 By Nasdaq GlobeNewswire
-
22 Dec 2022 06:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma to Participate in November Investor Events
09 Nov 2022 06:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma, Inc. Reports Third Quarter 2022 Financial Results and Business Update
03 Nov 2022 06:30:01 By Nasdaq GlobeNewswire
-
14 Oct 2022 06:30:00 By Nasdaq GlobeNewswire
-
13 Oct 2022 15:00:00 By Nasdaq GlobeNewswire
-
07 Oct 2022 06:30:00 By Nasdaq GlobeNewswire
-
20 Sep 2022 06:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma to Participate in September Investor Events
06 Sep 2022 06:30:00 By Nasdaq GlobeNewswire